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Synthesis of rhamnosylated arginine glycopeptides
and determination of the glycosidic linkage in
bacterial elongation factor P†
Siyao Wang,a Leo Corcilius,a Phillip P. Sharp,b Andrei Rajkovic,c Michael Ibba,c
Benjamin L. Parkerd and Richard J. Payne*a
A new class of N-linked protein glycosylation – arginine rhamnosylation – has recently been discovered as
a critical modification for the function of bacterial elongation factor P (EF-P). Herein, we describe the
synthesis of suitably protected a- and b-rhamnosylated arginine amino acid “cassettes” that can be
directly installed into rhamnosylated peptides. Preparation of a proteolytic fragment of Pseudomonas
aeruginosa EF-P bearing both a- and b-rhamnosylated arginine enabled the unequivocal determination
of the native glycosidic linkage to be a through 2D NMR and nano-UHPLC-tandem mass spectrometry
studies.
Protein glycosylation is the most ubiquitous post-translational
modication in nature, estimated to occur onmore than 50% of
human proteins.1 In eukaryotes, glycosylation is a key modu-
lator of biological recognition events, including cell adhesion,
differentiation and growth.2 In addition, the presence of glycans
can affect the structure and activity of a given protein and
aberrant glycan structures have been implicated in a number of
serious illnesses including cancer3 and autoimmune diseases.4
Eukaryotic protein glycosylation can be divided into two main
classes: O-glycosides, whereby a glycan is covalently linked to
the hydroxyl moiety of serine, threonine, tyrosine, hydroxylysine
or hydroxyproline with a- or b-anomeric conguration,5,6 or
N-glycosides, in which N-acetylglucosamine is b-linked to the
amide side chain of an asparagine residue (within an Asn-Xaa-
Ser/Thr consensus sequence).6,7 Importantly, the number of
eukaryotic proteins known to be glycosylated has dramatically
increased in recent years owing, in major part, to improvements
in glycoproteomic mass spectrometry methodologies.8–10
While glycosylation was initially deemed to be a modica-
tion exclusive to higher eukaryotic organisms, it is now estab-
lished that widespread O- and N-linked glycosylation of
bacterial proteins also occurs with similar linkage types to the
eukaryotic counterparts.11,12 However, since the eld of bacterial
protein glycosylation is still in its infancy, the effect of glyco-
sylation on structure and function is still not well understood.
Very recently, a number of new glycosylation motifs have been
discovered in bacteria, including S-glycosylation13–15 of cysteine
and N-glycosylation of the guanidine side chain of arginine
(Arg) residues.16–19 This latter modication was rst observed as
a b-N-acetyl-D-glucosamine (b-GlcNAc) modication on specic
Arg residues within human proteins bearing the death domain
motif, including TRADD, FADD, TNFR1 and the kinase
RIPK1.16,17 Intriguingly, this modication was shown to be
performed by a type III secretion system effector protein called
NleB produced by enteropathogenic strains of Escherichia coli.
Functionally, b-GlcNAcylation of specic Arg residues within
death domains by NleB prevents cell death pathways by block-
ing downstream signalling that would normally lead to
apoptosis or necroptosis of E. coli-infected cells.16,17
In more recent work, Lassak and Jung and co-workers and
Rajkovic et al. discovered L-rhamnosylation of Arg residues
within bacterial translation elongation factor P (EF-P), a protein
required for preventing ribosome stalling when translating
polyproline motifs.18,19 To date, the modication has been
discovered on EF-P of the g-proteobacterium Shewanella onei-
densis,18 the pathogenic bacteria Pseudomonas aeruginosa19 and
Neisseria meningitidis.20 In all three bacteria rhamnosylation of
Arg-32 was shown to be critical for the function of EF-P in
assisting translation and for the pathogenicity of P. aeruginosa
in vitro.18 The glycosylation was also shown to be performed by
EarP, a rhamnosyltransferase that employs dTDP-L-rhamnose
as the substrate. An important piece of information that was not
revealed in these studies was the stereochemistry at the
anomeric center of L-rhamnose appended to the side chain of
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Arg-32. Establishing the stereochemical conguration of this
centre is critical to determine the conformational effect of the
carbohydrate on the underlying peptide backbone and to
ascertain whether EarP is an inverting or retaining glycosyl-
transferase. In this work we were interested in developing an
efficient synthetic route toward suitably protected rhamnosy-
lated arginine amino acids with both a- and b-conguration. In
doing so we would be able to synthesize glycopeptides bearing
both rhamnosyl congurations for unequivocal determination
of the anomeric conguration of the rhamnose moiety on EF-P.
While this work was in progress, Li et al. reported an NMR study
on recombinant S. oneidensis EF-P that on the basis of a JC1,H1
coupling constant in an undecoupled HSQC experiment (J ¼
167 Hz) and the absence of a H1–H5 NOE (Nuclear Overhauser
Effect) would suggest that the rhamnose is a-congured at the
anomeric centre.21 Herein, we report a comprehensive analysis
of the stereochemistry of the rhamnosylation of P. aeruginosa
EF-P through 2D NMR spectroscopy, HPLC, nanoLC and
tandem mass spectrometric comparison of synthetic rhamno-
sylated peptides with the proteolytic fragment of isolated
P. aeruginosa EF-P and recombinant P. aeruginosa EF-P both
bearing the modication. Our studies provide strong evidence
that independently supports the notion that rhamnose is a-
linked to arginine in bacterial EF-P proteins. We also reveal that
the a-anomer of rhamnosylated arginine is congurationally
labile and undergoes base-promoted endocyclic ring opening
anomerization to the b-anomer which, to our knowledge has
not been previously observed in native N-linked glycosides.
We began by targeting proteolytic fragments of P. aeruginosa
EF-P bearing both a- and b-congured rhamnosylated Arg. Hu
and co-workers have reported the synthesis of peptides con-
taining N-GlcNAcylated22 and N-rhamnosylated21 Arg through
a solid-phase guanidinylation strategy whereby the requisite
glycosyl isothiourea was reacted with a resin-bound ornithine-
containing peptide. While the direct glycosylation of resin-
bound peptides is attractive from a synthetic standpoint, we
were concerned about the congurational stability of the
rhamnose linkage under the acidic and basic conditions
employed for cleavage and deprotection of the glycopeptide
following solid-phase peptide synthesis (SPPS). Therefore we
opted for a building block strategy, in which pre-fabricated a-
and b-rhamnosylated arginine building blocks 1 and 2 could be
robustly interrogated by 2D NMR techniques and the stability of
the individual glycosylamino acids examined under acidic and
basic conditions before direct incorporation into glycopeptides
as ‘cassettes’ through Fmoc-strategy SPPS (Scheme 1).
In order to mask the nucleophilicity of the guanidinium side
chain of Arg during SPPS, glycosylamino acid building blocks 1
and 2 were designed with an acid-labile 2,2,4,6,7-pentam-
ethyldihydrobenzofuran-5-sulfonyl (Pbf) side chain protecting
group, commonly employed for the protection of the parent
amino acid in Fmoc-SPPS.23 Synthesis of the two rhamnosylated
arginine building blocks 1 and 2 began with preparation of the
a- and b-congured glycosyl isothiocyanates 321 and 4, both of
which were accessed from rhamnosyl acetate 524 as a common
precursor (Scheme 1A). To access a-isothiocyanate 3, rhamnosyl
chloride 625 was treated with KSCN in the presence of catalytic
TBAI in reuxing acetonitrile. Under these conditions complete
1,2-trans (a) stereoselectivity was afforded due to anchimeric
assistance from the neighbouring acyloxy substituent.26 Alter-
natively, treatment of the glycosyl acetate 5 with SnCl4 and
TMSN3 provided glycosyl azide 7.27 This azide was reduced to
the glycosylamine using H2,Pd/C and, without purication, was
treated with thiophosgene and CaCO3 to afford the glycosyl
isothiocyanate 4 as predominantly the b-isomer (a : b 1 : 9).28 In
this case b-selectivity was presumed to result from base-cata-
lysed isomerization of the a-glycosylamine to the thermody-
namically favoured equatorial (b) isomer.27 Importantly,
2D NOESY NMR experiments of the two glycosyl isothiocyanates
3 and 4 conrmed the respective anomeric congurations
(see ESI†).
With the two rhamnosylated isothiocyanates 3 and 4 in
hand, we next sought to introduce the Pbf-protected guanidine
moiety (Scheme 1B). Direct treatment of isothiocyanates 3 and 4
with deprotonated Pbf-NH2 proved to be the optimal means to
generate-Pbf protected thioureas from 3 and 4 (Scheme 1B).29
These were not isolated, but rather treated directly with EtI and
K2CO3 in MeCN to afford ethyl isothioureas 8 and 9 in good
Scheme 1 (A) Stereoselective synthesis of a- and b-configured
rhamnosyl isothiocyanates 3 and 4; (B) synthesis of suitably protected
rhamnosylated arginine building blocks 1 and 2 with a- and b-
anomeric configuration, respectively.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 2296–2302 | 2297

























































































yields. Subsequent Hg(II)-promoted guanidinylation of each of
the isothioureas with Fmoc-Orn-OAll then gave the corre-
sponding glycosylamino acid derivatives 10 and 11 in excellent
yields. Finally, deprotection of the allyl ester moiety with tetra-
kis(triphenylphosphine)palladium(0) and phenylsilane affor-
ded the suitably protected rhamnosylated arginine building
blocks 1 and 2 ready for direct incorporation into glycopeptides
by Fmoc-SPPS.
At this stage, we set out to fully characterize building blocks 1
and 2 via NMR spectroscopy. Unfortunately, despite screening
a number of solvents and temperatures in NMR experiments,
proton signals from the pyranosyl ring were extremely broad,
thus making it difficult to assign the conguration of the
anomeric centre through 2D NMR experiments. This presumed
rotameric (or tautomeric) effect was alleviated by deprotection
of both the acetyl and Pbf moieties on building blocks 1 and 2
(via acidolytic deprotection of the Pbf followed by deacetylation
by treatment with sodium methoxide in MeOH). These condi-
tions were selected to mirror the intended deprotection
sequence of the rhamnosylated peptide following assembly by
Fmoc-SPPS. Deprotection of building block 2 (with b-anomeric
conguration) proceeded smoothly to afford triol 12 in 36%
yield following HPLC purication. The anomeric conguration
of 12 was unequivocally determined through 1D and 2D NMR
analysis (see ESI†). Unexpectedly, signicant anomerization was
observed when the same deprotection sequence was applied to
glycosylamino acid 1 bearing a-conguration at the anomeric
centre. Specically, upon treatment of 1 with TFA followed by
methoxide, a 4 : 5 a : b mixture of anomers was generated
(see ESI†). Upon further examination, it was determined that
the anomerization resulted from the deacetylation step, sug-
gesting a base-catalyzed mutarotation event. Thankfully,
reversal of the deprotection sequence (i.e. treatment with
NaOMe in MeOH prior to treatment with TFA) led to almost
complete retention of the anomeric stereochemistry (a : b 9 : 1),
suggesting that the presence of the electron-withdrawing Pbf
protecting group was necessary to suppress base-catalysed
anomerization. The conguration of the anomeric linkage was
able to be conrmed by 2D NOESY analysis of the deprotected
glycosylamino acids 12 and 13 (see ESI† for details). Impor-
tantly, b-congured rhamnosylated Arg 12 exhibited a distinct
NOE between H1 andH5 as well as between H1 andH3, whereas
these NOEs were absent in the corresponding a-anomer 13 (see
ESI†). HSQC experiments without 1H decoupling were also
performed to determine the 1H–13C coupling constant at C-1
(JC1,H1 ¼ 167 Hz for 13 and 154 Hz for 12, see ESI† for details).
Deprotected glycosylamino acids 12 and 13 were also found to
be stable in 0.1% TFA in MeCN/H2O, which is a common eluent
system used to purify peptides and glycopeptides. The above
nding that the deprotected rhamnosyl arginine isomerizes
under basic conditions highlights a unique behavior of the Arg-
N-linked glycan motif as the more common Asn-N-linked and
O-linked glycans are not susceptible to anomerization under
these conditions. Mechanistically, we propose that anomeriza-
tion of a-rhamnosylated arginine proceeds through endocyclic
ring opening that is facilitated by a lone pair on one of the
guanidine u-nitrogen atoms (see Scheme 2). This mechanistic
proposal is supported by previous observations that mannosyl
thiourea derivatives are susceptible to base-catalysed endocyclic
ring opening anomerization.30
With the two target rhamnosyl arginine building blocks 1
and 2 in hand, we began assembly of target peptide fragments
14 and 15 bearing a- and b-congured rhamnosyl arginine,
respectively via Fmoc-SPPS (Scheme 3). These glycopeptides
correspond to the Lys-C proteolysed fragment of P. aeruginosa
EF-P that has been characterized via MS(MS3).19 Synthesis of
these glycopeptides began by pre-loading of Chemmatrix® Tri-
tyl-OH resin with Fmoc-Lys(Boc)-OH, followed by standard
Fmoc-SPPS protocols to generate resin-bound hexapeptide 16.
Building blocks 1 or 2 (2.2 equiv.) were then coupled onto the
Scheme 2 Proposed base-catalyzed anomerization of a-rhamosy-
lated Arg to b-rhamnosylated Arg.
Scheme 3 Synthesis of Lys-C proteolytic fragments of P. aeruginosa
EF-P bearing a-rhamose (14) and b-rhamnose (15) anomeric
configurations.
2298 | Chem. Sci., 2017, 8, 2296–2302 This journal is © The Royal Society of Chemistry 2017

























































































resin-bound peptide using 1-[bis(dimethylamino)methylene]-
1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexauorophosphate
(HATU, 2.0 equiv.), 1-hydroxy-7-azabenzotriazole (HOAt, 3.0
equiv.)31 and sym-collidine (2.4 equiv.) as the base. These
conditions facilitated complete incorporation of the glyco-
sylamino acids (as judged by HPLC-MS analysis) to afford resin-
bound glycopeptide 17 and 18, which were further elongated to
the desired resin bound nonapeptides 19 and 20 following
standard Fmoc-SPPS protocols. Deprotection of the b-rhamno-
sylated peptide 20 was carried out through acidolytic side chain
deprotection and cleavage from the resin followed by Zemplén
deacetylation at pH 8–9 to afford peptide 15 in 30% isolated
yield (based on the original resin loading). In contrast, the
congurationally unstable a-rhamnosylated peptide 19 was
cleaved from the resin using a weakly acidic solution of hexa-
uoroisopropanol (HFIP) in DCM (30% v/v) to afford the fully
side-chain protected peptide, which was then carefully deace-
tylated under Zémplen conditions before global side chain
deprotection with TFA:i-Pr3SiH/H2O to afford predominantly
the a-glycopeptide 14 (9 : 1 a : b). This Zémplen deacetylation
reaction required careful monitoring by UPLC-MS as either
excessively high pH (>9) or extended reaction time still led to
signicant anomerization. Indeed, as with amino acid 13,
treatment of a-rhamnosylated EF-P glycopeptide 14 with dilute
methoxide (pH 9.0) for 2 h led to signicant anomerization to
the corresponding b-congured glycopeptide 15 (1 : 2 ratio
14 : 15, see Scheme 3 and ESI†). Unfortunately, an attempt to
avoid anomerization completely through on-resin deacetylation
of 19 with 10 vol% hydrazine monohydrate in DMF, followed by
cleavage from the resin with an acidic cocktail, led to signicant
anomerization [1 : 1 14(a) : 15(b), see ESI†]. Thus, careful off-
resin treatment with sodium methoxide in MeOH was deemed
optimal for deacetylation of the a-congured glycopeptide. The
optimal deprotection sequence of resin-bound 19 therefore
involved release of the side chain protected glycopeptide from
the resin using HFIP, careful deacetylation with methoxide
(pH 8–9) followed by global deprotection with an acidolytic
cocktail comprising TFA/i-Pr3SiH/H2O to afford predominantly
a-rhamnosylated peptide 14 (a : b 9 : 1) in 17% yield based on
the original resin loading. It should be noted that during the
above experiments we were also able to conrm the identity of
the proposed imine intermediate that forms via the base-cata-
lysed endocyclic ring opening anomerization (Scheme 2).
Specically, following co-treatment of 14 with methoxide and
sodium borohydride, the ring opened imine could be trapped as
the corresponding amine (see ESI†).
We next extensively characterized glycopeptides 14 and 15
with a view to performing comparative studies with native P.
aeruginosa EF-P for determination of the anomeric congura-
tion of the rhamnose moiety in the native protein. 2D NMR
experiments were initially used to unequivocally conrm that
the rhamnopyranosyl moiety of glycopeptides 14 and 15 was a-
and b-congured, respectively. We rst performed 1H coupled
HSQC experiments that provided a 1H–13C coupling constant at
the anomeric centre of 167 Hz for the a-linkage of 14 and 156 Hz
for the b-linkage of 15, very similar to the values obtained for the
parent rhamnosylamino acids 1 and 2 (vide supra) (Fig. 1A). It
should be noted that the coupling constant for 14 was also in
agreement with that determined for recombinant S. oneidensis
EF-P homologue (1JC–H ¼ 167 Hz) reported by Li et al.21 Selective
ROESY irradiation at H1 was also performed which showed
a NOE with H5 of 15 (with a diaxial H1–H5 relationship, see
Fig. 1B) but not for 14 (see Fig. 1C). Finally, we developed
analytical HPLC-MS conditions to separate the two anomeric
glycopeptides 14 and 15 with a retention time difference of
1 min (see Fig. 1D for individual and overlayed HPLC traces).
Having prepared the two possible anomers of the Lys-C
proteolysed glycopeptides of P. aeruginosa EF-P (14 and 15) and
conrmed their anomeric stereochemistry, we next performed
comparative analysis to the Lys-C glycopeptide produced from
isolated P. aeruginosa EF-P prepared as reported previously19 via
nano-ultra high pressure liquid chromatography (nanoUHPLC)
coupled to tandem mass spectrometry (see ESI†). Separation of
the two anomeric rhamnosylated glycopeptides 14 and 15 was
achieved with nanoUHPLC using isocratic elution on a 50 cm
column (Fig. 2A). Analysis of the Lys-C proteolysed glycopeptide
fragment of puried P. aeruginosa EF-P clearly showed a reten-
tion time alignment with the a-rhamnosylated glycopeptide 14
providing convincing evidence that the rhamnose moiety
appended to Arg-32 of P. aeruginosa EF-P is a-linked. We further
conrmed this retention time-based evidence by spiking either
the synthetic a-rhamnosylated (14) or b-rhamnosylated glyco-
peptide (15) into a sample of Lys-C proteolysed P. aeruginosa EF-
P, followed by analysis by nanoUHPLC-MS/MS (see Fig. 81,
ESI†). Addition of the a-rhamnosylated (14) glycopeptide
increased the intensity of a single chromatographic peak while
spiking in the b-rhamnosylated glycopeptide (15) produced two
peaks of similar intensity, thus further supporting the a-
anomeric conguration of rhamnose in P. aeruginosa EF-P.
Interestingly, we also observed <5% of the b-rhamnosylated
peptide in the proteolysed sample. This observation is consis-
tent with the endocyclic ring opening anomerization observed
during preparation of the synthetic glycopeptides. It is impor-
tant to note that this anomerization occurred despite only
neutral buffer conditions being used and suggests that rham-
nosylated peptides and proteins (whether expressed, isolated or
synthesised) must be handled carefully during isolation, puri-
cation and other manipulations to prevent extensive anome-
rization. In order to further strengthen our observations on the
anomeric conguration of rhamnose in EF-P, we produced
recombinant P. aeruginosa EF-P in E. coli and performed in vitro
rhamnosylation with EarP using dTDP-L-rhamnose as
a substrate (see ESI†).18,19 Analysis of the Lys-C proteolysed
glycopeptide fragment also suggested a-conguration of the
rhamnose moiety based on retention time analysis with
synthetic 14 and 15 by nanoUHPLC. Finally, we performed
fragmentation of the rhamnosylated glycopeptide from P. aer-
uginosa with ETD MS/MS which localised the glycosylation site
to Arg3219 (see Fig. 82, ESI†).
To further conrm the a-congurational assignment of EF-P
rhamnosylation, MS/MS analysis was performed on glycopep-
tides 14 and 15 bearing a- and b-conguration, respectively, and
the data compared to glycopeptides produced from Lys-C
digestion of isolated P. aeruginosa EF-P and the recombinant
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 2296–2302 | 2299

























































































protein with in vitro EarP-transferred rhamnose. Subtle differ-
ences were observed in the fragmentation patterns between the
two anomeric rhamnosylated glycopeptides 14 and 15 (Fig. 2B
and C). This included a difference in the intensity of the doubly
charged fragment arising from a loss of the rhamnose sugar
from the triply charged precursor-ion under collision-induced
dissociation (CID). The difference in stability of the a- verses b-
linkage prompted us to investigate relative fragment ion
distributions under CID MS/MS as a further tool to differentiate
between the two anomers. The synthetic a- and b-rhamnosy-
lated glycopeptides were analysed by CID and higher collisional
dissociation (HCD) MS/MS with increasing normalised collision
energies (NCEs), specically 10–40 NCE with steps of 5 NCE. As
expected, no fragment ion masses were unique to the a- or
b-linkage with either fragmentation approach. However, we
observed subtle differences in the intensity of the fragment-ion
distributions. The intensity of the doubly charged fragment
arising from a loss of the rhamnose sugar from the triply
charged precursor-ion was the major ion signicantly different
for the two anomers with either CID or HCD. We hypothesise
that this diagnostic fragment ion may arise from differences in
the C–N bond strength at the anomeric centre. Specically, due
to back donation of electron density from the endocyclic oxygen
into the s* of the C1–N bond in the a-anomer (i.e. the endo
anomeric effect) the C–N bond of this anomer would be ex-
pected to be longer and weaker than the corresponding
b-anomer, thus leading to more extensive loss of rhamnose. The
optimal fragmentation energy to maximize the intensity
differences and distinguish between a- and b-anomers was 10–
15% NCE and 30–40% NCE for HCD and CID, respectively (see
Fig. 83, ESI†). However, the fragmentation efficiency of HCD at
15 NCE was only approximately 20% with the un-fragmented
precursor ion being the major ion in MS/MS (see Fig. 84, ESI†).
Therefore, all further work was performed with CID at 35 NCE
which produces the maximal difference in the diagnostic frag-
ment ion intensity between a- and b-anomers, and produces
extensive peptide backbone fragmentation efficiency.
CID MS/MS analysis of the Lys-C glycopeptide fragment from
isolated P. aeruginosa EF-P displayed very similar fragmentation
patterns to the a-rhamnosylated glycopeptide 14 (Fig. 2D).
Quantication of this fragment-ion intensity (normalized to the
precursor-ion intensity) highlighted a signicant difference
between the a- and b-congured glycopeptides (Fig. 2E).
The intensity of this fragment-ion from glycopeptides
produced from P. aeruginosa EF-P and the in vitro rhamnosylated
recombinant EF-P are clearly consistent with the a-conguration.
Fig. 1 (A) Zoom in of the 1H–13C HSQC without proton decoupling for: H-SGR(a-Rha)NAAVVK-OH (14), 1JCH ¼ 167 Hz (left) and H-SGR(b-Rha)
NAAVVK-OH (15), 1JCH ¼ 156 Hz (right); (B) selective ROESY experiments for H-SGR(b-Rha)NAAVVK-OH (15). Black ¼ zoom in of 1H NMR
spectrum, blue¼ selected ROESY by irradiating H-1; red: selected ROESY by irradiating H5. The through-space NOE relationship between diaxial
H5 and H1 can be observed; (C) selective ROESY experiments for H-SGR(a-Rha)NAAVVK-OH (14). Black ¼ zoom in of 1H NMR spectrum, blue ¼
selected ROESY by irradiating H-5; red: selected ROESY by irradiating H1. No NOE was observed; (D) analytical HPLC traces of H-SGR(a-Rha)
NAAVVK-OH 14 (top), H-SGR(b-Rha)NAAVVK-OH 15 (middle), overlay of HPLC chromatograms of 14 and 15 (bottom); gradient: 100% A for 2min
then 0–20% B over 30 min, Waters Atlantis® T3 C18 Column at 0.2 mL min1.
2300 | Chem. Sci., 2017, 8, 2296–2302 This journal is © The Royal Society of Chemistry 2017

























































































Taken together, the NMR, UHPLC and tandem mass spectrom-
etry data provide strong evidence that rhamnosylation of Arg-32
in P. aeruginosa EF-P (and by extension the conserved Arg residue
of other bacterial EF-P proteins21) is a-congured.
Conclusions
N-Linked rhamnosylation has recently been uncovered as an
unusual modication of a conserved Arg residue in bacterial EF-
P proteins that is critical for its role in preventing ribosome
stalling during polyproline translation. In this work we have
described an efficient synthetic route to suitably protected a-
and b-rhamnosylated arginine ‘cassettes’ that can be directly
incorporated into Fmoc-SPPS for the preparation of rhamno-
sylated peptides. We also describe the synthesis of Lys-C
proteolytic fragments of P. aeruginosa EF-P bearing both a- and
b-rhamnosylated arginine. Through a combination of 2D NMR
and nano-UHPLC coupled to tandem mass spectrometry and
using isolated and recombinant P. aeruginosa EF-P as standards
we provide evidence that strongly suggests that the native
protein bears an a-congured rhamnose residue on Arg-32.
These ndings complement a recent anomeric coupling
constant analysis on the full length S. oneidensis homologue.21
Finally, we demonstrate that the a-rhamnosylated arginine
moiety can undergo unusual endocyclic ring opening anome-
rization to the b-anomer. As such, synthetic or recombinant
glycopeptides and glycoproteins bearing a-rhamnosyl arginine
must be carefully handled to prevent unwanted loss of cong-
urational purity. Importantly, the work described here lays the
foundation for future synthetic and biochemical studies on
bacterial glycopeptides and glycoproteins, including those
bearing the rhamnosylated arginine motif, with a view to
understanding the importance of glycosylation for bacterial
protein structure and function.
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28 J. L. Jiménez Blanco, B. Sylla, C. Ortiz Mellet and J. M. Garćıa
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